Skip to main content

Advertisement

Log in

Quantitative assessment of the association between GSTM1 null genotype and laryngeal cancer risk

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Previous studies investigating the association between glutathione S-transferase M1 (GSTM1) null genotype and laryngeal cancer risk reported controversial results. Thus, a meta-analysis was performed to clarify the effect of GSTM1 null genotype on laryngeal cancer risk. A literature search was performed for all possible studies. We estimated summary odd ratio (OR) with its 95 % confidence interval (95 % CI) to assess the association. Subgroup analyses were performed by ethnicity or the sample size. 24 individual case–control studies involving a total of 2,809 laryngeal cancer cases and 4,478 controls were finally included into this meta-analysis. Meta-analyses of total 24 studies showed the GSTM1 null genotype was significantly associated with increased laryngeal cancer risk (random-effects OR = 1.44, 95 % CI 1.19–1.73, P < 0.001). Subgroup analyses by ethnicity showed that the GSTM1 null genotype was associated with increased laryngeal cancer risk in both Caucasians (fixed-effects OR = 1.17, 95 % CI 1.04–1.33, P = 0.012) and Asians (random-effects OR = 1.89, 95 % CI 1.28–2.77, P = 0.001). Also, subgroup analyses by sample size also further identified this association above. The cumulative meta-analyses showed a trend of more obvious association between GSTM1 null genotype and increased risk of laryngeal cancer as information accumulated by year. Meta-analysis of available data suggests that GSTM1 null genotype contributes to increased laryngeal cancer risk in both Caucasians and East Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  2. Bosetti C, Garavello W, Gallus S, La Vecchia C (2006) Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies. Oral Oncol 42(9):866–872

    Article  PubMed  Google Scholar 

  3. Sadri M, McMahon J, Parker A (2006) Laryngeal dysplasia: aetiology and molecular biology. J Laryngol Otol 120(3):170–177

    Article  PubMed  Google Scholar 

  4. Nadal A, Cardesa A (2003) Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 442(1):1–7

    PubMed  CAS  Google Scholar 

  5. Ha PK, Califano JA 3rd (2002) The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 35(5):993–1012

    Article  PubMed  Google Scholar 

  6. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88

    Article  PubMed  CAS  Google Scholar 

  7. Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61(3):154–166

    Article  PubMed  CAS  Google Scholar 

  8. Ruwali M, Singh M, Pant MC, Parmar D (2011) Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer. Xenobiotica 41(12):1122–1130

    Article  PubMed  CAS  Google Scholar 

  9. Lourenco GJ, Silva EF, Rinck-Junior JA, Chone CT, Lima CS (2011) CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma. Tumour Biol 32(6):1209–1215

    Article  PubMed  CAS  Google Scholar 

  10. Risch A, Ramroth H, Raedts V, Rajaee-Behbahani N, Schmezer P, Bartsch H, Becher H, Dietz A (2003) Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. Pharmacogenetics 13(4):225–230

    Article  PubMed  CAS  Google Scholar 

  11. Matthias C, Bockmuhl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, Hand P, Fryer AA, Strange RC (1998) Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8(2):91–100

    Article  PubMed  CAS  Google Scholar 

  12. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg 128(5):674–680

    Article  PubMed  CAS  Google Scholar 

  13. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574(1–2):112–123

    PubMed  CAS  Google Scholar 

  14. Chatzimichalis M, Xenellis J, Tzagaroulakis A, Sarof P, Banis K, Gazouli M, Bibas A (2010) GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population. J Laryngol Otol 124(3):318–323

    Article  PubMed  CAS  Google Scholar 

  15. Bardakci F, Canbay E, Degerli N, Coban L, Canbay EI (2003) Relationship of tobacco smoking with GSTM1 gene polymorphism in laryngeal cancer. J Cell Mol Med 7(3):307–312

    Article  PubMed  CAS  Google Scholar 

  16. Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H, Monden M (1999) Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 80(5):685–688

    Article  PubMed  CAS  Google Scholar 

  17. Cabelguenne A, Loriot MA, Stucker I, Blons H, Koum-Besson E, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P, De Waziers I (2001) Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 93(5):725–730

    Article  PubMed  CAS  Google Scholar 

  18. Coutelle C, Ward PJ, Fleury B, Quattrocchi P, Chambrin H, Iron A, Couzigou P, Cassaigne A (1997) Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet 99(3):319–325

    Article  PubMed  CAS  Google Scholar 

  19. Jahnke V, Strange R, Matthias C, Fryer A (1997) Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma. Eur Arch Otorhinolaryngol 254(Suppl 1):S147–S149

    Article  PubMed  Google Scholar 

  20. Hong YJ, Lee JK, Lee GH, Hong SI (2000) Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med 38(9):917–919

    Article  PubMed  CAS  Google Scholar 

  21. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Caballero M, Cruellas F, Raya A, Dicenta M, Corbella J (2002) Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 187(1–2):95–101

    Article  PubMed  CAS  Google Scholar 

  22. Acar H, Ozturk K, Muslumanoglu MH, Yildirim MS, Cora T, Cilingir O, Ozer B (2006) Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk. Cancer Genet Cytogenet 169(2):89–93

    Article  PubMed  CAS  Google Scholar 

  23. Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT (2006) Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(11):2196–2202

    Article  PubMed  CAS  Google Scholar 

  24. Jourenkova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A (1998) Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prev 7(1):19–23

    PubMed  CAS  Google Scholar 

  25. Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA (2010) Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev 11(4):881–885

    PubMed  CAS  Google Scholar 

  26. Attia J, Thakkinstian A, D’Este C (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56(4):297–303

    Article  PubMed  Google Scholar 

  27. Petitti DB (2000) Meta-analysis, decision analysis, and cost effectiveness analysis: methods for quantitative synthesis in medicine, 2nd edn. Oxford University Press, New York

    Google Scholar 

  28. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N (2003) The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348(12):1170–1175

    Article  PubMed  Google Scholar 

  29. Bhopal R (2004) Glossary of terms relating to ethnicity and race: for reflection and debate. J Epidemiol Community Health 58(6):441–445

    Article  PubMed  CAS  Google Scholar 

  30. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    PubMed  CAS  Google Scholar 

  31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  32. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  Google Scholar 

  33. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129

    Article  Google Scholar 

  34. Thompson SG, Higgins J (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21(11):1559–1573

    Article  PubMed  Google Scholar 

  35. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327(4):248–254

    Article  PubMed  CAS  Google Scholar 

  36. Zintzaras E, Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61(7):634–645

    Article  PubMed  Google Scholar 

  37. Muellerleile P, Mullen B (2006) Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health 96(3):515–522

    Article  PubMed  Google Scholar 

  38. Coon CS (1972) The races of Europe. Greenwood Press, New York

    Google Scholar 

  39. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316(7129):469 (author reply 470–461)

    Article  PubMed  CAS  Google Scholar 

  40. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  41. Li L, Lin P, Deng YF, Zhu ZL, Lu HH (2004) Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1. Zhonghua Er Bi Yan Hou Ke Za Zhi 39(1):2–7

    PubMed  Google Scholar 

  42. Yan Y, Zhou W (2003) GSTM1 null genotype and susceptibility of laryngeal carcinoma. Nantong Yi Xue Yuan Bao 23(3):255–257

    Google Scholar 

  43. Tian S, Zhang J, Xiao Q, Zhai J, Yan X, Huang M, Chen F, Li Q, Guan Z (2011) The association between genetic polymorphisms of GSTM1, GSTT1, GSTP1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 25(5):204–210

    PubMed  Google Scholar 

  44. Li Q, Wang L, Chen Y, Du Y, Kong P, Li Y, Xu X (2009) Polymorphisms of GSTM1, GSTT1 and susceptibility of laryngeal and hypopharyngeal carcinomas. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 23(24):1105–1107, 1111

  45. Lei DP, Pan X, Guo CH, Xu F, Zhang L, Liu D, Luan X (2002) Larynx cancer risk in relation to glutathione S-transferase M1 null genotype. Chin J Med Genet 19(6):74–76

    Google Scholar 

  46. Unal M, Tamer L, Ates NA, Akbas Y, Pata YS, Vayisoglu Y, Ercan B, Gorur K, Atik U (2004) Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 25(5):318–322

    Article  PubMed  CAS  Google Scholar 

  47. Canova C, Richiardi L, Merletti F, Pentenero M, Gervasio C, Tanturri G, Garzino-Demo P, Pecorari G, Talamini R, Barzan L, Sulfaro S, Franchini G, Muzzolini C, Bordin S, Pugliese GN, Macri E, Simonato L (2010) Alcohol, tobacco and genetic susceptibility in relation to cancers of the upper aerodigestive tract in northern Italy. Tumori 96(1):1–10

    PubMed  CAS  Google Scholar 

  48. Leme CV, Raposo LS, Ruiz MT, Biselli JM, Galbiatti AL, Maniglia JV, Pavarino-Bertelli EC, Goloni-Bertollo EM (2010) GSTM1 and GSTT1 genes analysis in head and neck cancer patients. Rev Assoc Med Bras 56(3):299–303

    Article  PubMed  Google Scholar 

  49. Sharma R, Panda NK, Khullar M (2010) Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis 16(7):668–673

    Article  PubMed  CAS  Google Scholar 

  50. Matthias C, Jahnke V, Hand P, Fryer AA, Strange RC (1999) Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck. Laryngorhinootologie 78(4):182–188

    Article  PubMed  CAS  Google Scholar 

  51. Matthias C, Jahnke V, Fryer AA, Strange RC (2002) Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer. Laryngorhinootologie 81(6):406–412

    Article  PubMed  CAS  Google Scholar 

  52. Gronau S, Konig-Greger D, Rettinger G, Riechelmann H (2000) GSTM1 gene polymorphism in patients with head and neck tumors. Laryngorhinootologie 79(6):341–344

    Article  PubMed  CAS  Google Scholar 

  53. Jahnke V, Matthias C, Fryer A, Strange R (1996) Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg 172(6):671–673

    Article  PubMed  CAS  Google Scholar 

  54. Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT (2009) Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol 135(8):1081–1090

    Article  PubMed  CAS  Google Scholar 

  55. Kumar V, Murthy AK, Suresh K (2011) Glutathione S-transferase M1 and T1 Status and the Risk of Laryngeal Cancer: a Meta-analysis. Asian Pac J Cancer Prev 12(9):2221–2226

    PubMed  Google Scholar 

  56. Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335(7626):914–916

    Article  PubMed  Google Scholar 

  57. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394

    Article  PubMed  Google Scholar 

  58. Zhang R, Xu G, Chen W, Zhang W (2011) Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies. Mol Biol Rep 38(4):2491–2497

    Article  PubMed  CAS  Google Scholar 

  59. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W (2010) Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 53(3):508–518

    Article  PubMed  Google Scholar 

  60. Economopoulos KP, Sergentanis TN (2010) GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 46(9):1617–1631

    Article  PubMed  CAS  Google Scholar 

  61. Qiu LX, Wang K, Lv FF, Chen ZY, Liu X, Zheng CL, Li WH, Zhu XD, Guo WJ, Li J (2011) GSTM1 null allele is a risk factor for gastric cancer development in Asians. Cytokine 55(1):122–125

    Article  PubMed  CAS  Google Scholar 

  62. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2010) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat 121(3):703–708

    Article  PubMed  CAS  Google Scholar 

  63. Economopoulos KP, Sergentanis TN, Vlahos NF (2010) Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis. Int J Gynecol Cancer 20(5):732–737

    Article  PubMed  Google Scholar 

  64. Economopoulos KP, Choussein S, Vlahos NF, Sergentanis TN (2010) GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 20(9):1576–1580

    PubMed  Google Scholar 

  65. Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM (2003) Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 206(3):149–171

    Article  PubMed  CAS  Google Scholar 

  66. Reszka E, Wasowicz W, Gromadzinska J (2006) Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr 96(4):609–619

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongchao Yao.

Additional information

H. Xiao and M. Li contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, H., Li, M., Tian, L. et al. Quantitative assessment of the association between GSTM1 null genotype and laryngeal cancer risk. Eur Arch Otorhinolaryngol 270, 615–622 (2013). https://doi.org/10.1007/s00405-012-2148-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-2148-7

Keywords

Navigation